FibroBiologics releases third batch of CYWC628 drug product
FibroBiologics said it released a third batch of CYWC628 drug product for its Phase 1/2 diabetic foot ulcer clinical trial.
Story updates
12:31:55 PM UTC
SquawkNews
FBLG - FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.